Prediction of recurrence in low and intermediate risk non-muscle invasive bladder cancer by real-time quantitative PCR analysis: CDNA microarray results

Neoplasma

Volumn 60, Issue 3, 2013, Pages 295-301

  Mares, J ^a   Szakacsova, M ^b   Soukup, V ^b   Duskova, J ^b   Horinek, A ^b   Babjuk, M ^c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

Bladder cancer; Gene expression microarrays; Non muscle invasive urothelial tumors

Indexed keywords

FODRIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; LIPOCORTIN 1; NINJURIN 1; PANCREATIC RIBONUCLEASE; PEPTIDES AND PROTEINS; PHOSPHOSERINE AMINOTRANSFERASE 1; RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR; RIBONUCLEASE; SYNAPTOGYRIN; TETRASPANIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; MESSENGER RNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER STAGING; CLINICAL ARTICLE; DNA MICROARRAY; FEMALE; FLJ32252 GENE; GENE; GENE EXPRESSION; GNE GENE; HISTOLOGY; HUMAN; HUMAN TISSUE; HYBRIDIZATION; LAMINA PROPRIA; MALE; MIDDLE AGED; NON MUSCLE INVASIVE BLADDER CANCER; NUCLEOTIDE SEQUENCE; PRICKLE 1 GENE; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR BIOPSY; TUMOR INVASION; TUMOR VOLUME; VERY ELDERLY; WDR34 GENE; BLADDER TUMOR; COMPARATIVE STUDY; GENE EXPRESSION PROFILING; GENETICS; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

MLCS; MLOWN;

EID: 84879387644     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2013_0391     Document Type: Article

References (28)

1. http://www.svod.cz/
2. PARKIN DM, BRAY F, FERLAY J, PISANI P Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108. http://dx.doi.org/10.3322/canjclin.55.2.74
3. BLAVERI E, SIMKO JP, KORKOLA JE, BREWER JL, BAEHNER F et al. Bladder cancer outcome and subtype classification by gene expression. Clin Cancer Res 2005; 11: 4044-4055. http://dx.doi.org/10.1158/1078-0432.CCR-04-2409
4. LANDIS SH, MURRAY T, BOLDEN S, WINGO PA Cancer statistics, 1999. CA Cancer J Clin 1999; 49: 8-31. http://dx.doi.org/10.3322/canjclin.49.1.8
5. LAMM DL Long-term results of intravesical therapy for superficial bladder cancer. Urol Clin North Am 1992; 19: 573-580.
6. BABJUK M, SOUKUP V, MARES J, DUSKOVA J, PECEN L et al. Association of PAX5 expression with clinical outcome in patients with TaT1 transitional cell carcinoma of the bladder. Urology 2006; 67: 756-761. http://dx.doi.org/10.1016/j.urology.2005.10.053
7. SANCHEZ-CARBAYO M, SOCCI ND, LOZANO J, LI W, CHARYTONOWICZ E et al. Gene discovery in bladder cancer progression using cDNA microarray. Am J Pathol 2003; 163: 505-516. http://dx.doi.org/10.1016/S0002-9440(10)63679-6
8. DYRSKJOT L, ZIEGER K, KRUHOFFER M, THYKJAER T, JENSEN JL et al. A molecular signature in superficial bladder carcinoma predicts clinical outcome, Clin Cancer Res 2005; 11: 4029-4036. http://dx.doi.org/10.1158/1078-0432.CCR-04-2095
9. SOBIN LH, WITTEKIND C In: Sobin LH, Wittekind C, editors. UICC TNM classification of malignant tumors, 5th ed., New York: Wiley Liss, 1997: 187-190.
10. STONE R II, SABICHI A, GILL G, LEE IL, ADEGBOYEGA P et al. Identification of genes correlated with early stage bladder cancer progression. Cancer Prev Res 2010; 3: 776-786. http://dx.doi.org/10.1158/1940-6207.CAPR-09-0189
11. SANCHEZ-CARBAYO M, SOCCI ND, CHARYTONOWICZ E, LU M, PRYSTOWSKY M et al. Molecular profiling of bladder cancer using cDNA microarrays: defining histogenesis and biological phenotypes. Cancer Res 2002; 62: 6973-6980.
12. KIM WJ, KIM EJ, KIM SK, KIM YJ, HA YS et al. Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer. Mol Cancer 2010; 9: 3. http://dx.doi.org/10.1186/1476-4598-9-3
13. ELSAMMAN E, FUKUMORI T, EWIS AA, ALI N, KAJIMOTO K et al. Differences in gene expression between noninvasive and invasive transitional cell carcinoma of human bladder using complementary deoxyribonucleic acid microarray: preliminary report. Urol Oncol 2006; 24: 109-115. http://dx.doi.org/10.1016/j.urolonc.2005.07.011
14. KAWAKAMI K, ENOKIDA H, TACHIWADA T, GOTANDA T, TSUNEYOSHI K et al. Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profilling. Oncol Rep 2006; 16: 521-531.
15. SCHULTZ IJ, WESTER K, STRAATMAN H, KIEMENEY LA, BABJUK M et al. Prediction of recurrence in Ta urothelial cell carcinoma by real-time quantitative analysis: A microarray validation study. Int J Cancer 2006; 119: 1915-1919. http://dx.doi.org/10.1002/ijc.22059
16. RIESTER M, TAYLOR JM, FEIFER A, KOPPIE T, ROSENBERG JE et al. Combination of a novel gene expression signature with a clinical monogram improves the prediction of survival in high-risk bladder cancer. Clin Cancer Res 2012; 18: 1323-1333. http://dx.doi.org/10.1158/1078-0432.CCR-11-2271
17. LIM LH, PERVAIZ S Annexin 1: the new face of an old molecule. FASEB J 2007; 21: 968-975. http://dx.doi.org/10.1096/fj.06-7464rev
18. KRAUSE S, HINDERLICH S, AMSILI S, HORSTKORTE R, WIENDL H et al. Localization of UDP-GlcNAc 2-epimerase/ ManAc kinase (GNE) in the Golgi complex and the nucleus of mammalian cells. Exp Cell Res 2005; 304: 365-379. http://dx.doi.org/10.1016/j.yexcr.2004.11.010
19. SUGITA S, JANZ R, SUDHOF TC Synaptogyrins regulate Ca2+-dependent exocytosis in PC12 cells. J Biol Chem 1999; 274: 18893-18901. http://dx.doi.org/10.1074/jbc.274.27.18893
20. ZHANG N, SANDERS AJ, YE L, KYNASTON HG, JIANG WG Expression of vascular endothelial growth inhibitor (VEGI) in human urothelial cancer of the bladder and its effect on the adhesion and migration of bladder cancer cells in vitro. Anticancer Res 2010; 30: 87-95.
21. CHAN DW, CHAN CY, YAM JW, CHING YP, NG IO Prickle-1 negatively regulates Wnt/beta-catenin pathway by promoting Dishevelled ubiquitination/degradation in liver cancer. Gastroenterology 2006; 131: 1218-1227. http://dx.doi.org/10.1053/j.gastro.2006.07.020
22. WANG L, ZHU JS, SONG MQ, CHEN GQ, CHEN JL Comparison of gene expression profiles between primary tumor and metastatic lesions in gastric cancer patients using laser microdissection and cDNA microarray. World J Gastroenterol 2006; 12: 6949-6954.
23. LETO TL, FORTUGNO-ERIKSON D, BARTON D, YANGFENG TL, FRANCKE U et al. Comparison of nonerythroid alpha-spectrin genes reveals strict homology among diverse species. Mol Cell Biol 1988; 8: 1-9.
24. CHEN L, ZHU YY, ZHANG XJ, WANG GL, LI XY et al. TSPAN1 protein expression: A significant prognostic indicator for patients with colorectal adenocarcinoma. Word J Gastroenterol 2009; 15: 2270-2276. http://dx.doi.org/10.3748/wjg.15.2270
25. THIESEN S, KUBART S, ROPERS HH, NOTHWANG HG Isolation of two novel human RhoGEFs, ARHGEF3 and ARHGEF4, in 3p13-21 and 2q22. Biochem Biophys Res Commun 2000; 273: 364-369. http://dx.doi.org/10.1006/bbrc.2000.2925
26. FRIEDRICHS J, ROSENBERG R, MAGES J, JANSSEN KP, MAECKL C et al. Gene expression profiles of different clinical stages of colorectal carcinoma: toward to a molecular genetic understanding of tumor progression. Int J Colorectal Dis 2005; 20: 391-402. http://dx.doi.org/10.1007/s00384-004-0722-1
27. CASTELAO JE, YUAN JM, GADO-DOMINGUEZ M, YU MC, ROSS RK Non-steroidal anti-inflammatory drugs and bladder cancer prevention. Br J Cancer 2000; 82: 1364-1369.
28. FRANK GA, ZAVALISHINA LE, ANDREEVA IuIu Status of extracellular matrix and adhesion markers in urothelial cancer of the urinary bladder. Arkh Patol 2005; 67: 11-14.